Pharmacokinetic Enhancement of Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: A Cost Reduction Strategy to Address Global Disparities in Access.
Eunjin HongMarco ZampoliPaul M BeringerPublished in: Clinical pharmacology and therapeutics (2024)